The Dhillon family seemed to be living the California dream, enjoying the waterway just steps from their home on Naples Island. But a little more than five years ago, when their daughter, Daya, began feeling ill, the Dhillon family’s California dream morphed into a medical nightmare.
The R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center (UMMC) hosted its 32nd annual Shock Trauma Heroes Celebration Saturday, honoring more than 40 trauma professionals and first responders who worked together to save the life of a 51-year-old highway construction worker whose legs were crushed when he was struck by a car on I-95 and pinned against his truck. He nearly bled to death from his injuries.
The new patient guidelines for Marginal Zone Lymphoma guidelines are the latest in NCCN’s library of NCCN Guidelines for Patients®, published through funding from the NCCN Foundation® and available online free of charge.
Elevated levels of per- and polyfluoroalkyl substances (PFAS) were associated with higher total cholesterol and non-HDL cholesterol in GenX Exposure Study participants’ blood. The effects were more pronounced in older people.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Matthew Matasar, MD, MS, as Chief of Blood Disorders at New Jersey’s leading cancer center and the only one in the state designated as a Comprehensive Cancer Center by the National Cancer Institute. In this role, he will oversee the Sections of Hematologic Malignancies; Transplant and Cell Therapy; and Benign Hematology.
People who have sickle cell disease (SCD), a genetic disorder that affects red blood cells, have reduced life expectancy and may face many challenges in their life. However, there are steps they can take to live the healthiest life possible despite this disease.
A new study from Washington University School of Medicine in St. Louis suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects in the days and weeks after CAR-T cell therapy.
Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two different antigens at the same time—they are meant to enhance the immune system’s destruction of tumor cells.
Gene variants associated with a person’s blood type may be linked to their risk of early stroke, according to a new meta-analysis published in the August 31, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. The meta-analysis included all available data from genetic studies that included young adult ischemic stroke, which is caused by a blockage of blood flow to the brain.
Russia’s invasion of Ukraine created a dire situation for children with cancer and blood disorders. In response, the St. Jude Global initiative of St. Jude Children’s Research Hospital banded together with international partners and formed SAFER Ukraine. An account appears in The Lancet Haematology.
The research arm of the U. S. Army has awarded Case Western Reserve University blood surrogate pioneer Anirban Sen Gupta a four-year, $2.5 million grant to advance and optimize his latest nanotechnology to stop bleeding from battlefield injuries.
The new technology devised by Sen Gupta and his team is called “SanguiStop.” It allows a clot-promoting enzyme called thrombin to be intravenously delivered in a targeted manner to a bleeding area—especially to the site of internal injuries.
Cedars-Sinai Cancer investigators have created a blood test that uses a technology made commonly available during the COVID-19 pandemic to detect the most common form of liver cancer—at an early enough stage that cure is possible. Their work was published online in the peer-reviewed journal Hepatology.
A clinical trial of patients with COVID-19 led by investigators at the TIMI Study Group at Brigham and Women’s Hospital and the Critical Care Cardiology Trials Network (CCCTN) has found that full-dose anticoagulation lowers the risk of blood clotting complications compared with standard-dose prophylactic anticoagulation.
Bone health requires a balanced activity of various bone cell types including bone-forming osteoblasts and bone-resorbing osteoclasts. Osteoporosis occurs when osteoclasts dominate without adequate bone formation to compensate.
The Association for the Advancement of Blood and Biotherapies (AABB) has released clinical practice guidelines for the appropriate use of COVID-19 convalescent plasma (CCP) in hospital and outpatient settings. Based on two living systematic reviews of randomized controlled trials (RCTs), the guidelines provide five specific recommendations for treating patients with COVID-19 and suggest that CCP is most effective when transfused with high neutralizing titers to infected patients early after symptom onset. The guidelines are published in Annals of Internal Medicine.
Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST™) announced today the commencement of U.S. pivotal clinical trials for its eQUANT system, which will be used to support a submission for FDA clearance.
Individuals with blood-related cancers are more likely to experience a COVID-19 infection even after being vaccinated, a University of Kansas Cancer Center study has found.
Nanoparticles (red) are taken up by immune cells (green with blue nuclei). Researchers at Washington University School of Medicine in St. Louis have shown that an experimental nanoparticle-based drug therapy protects mice from sudden death due to the rupture of a major blood vessel in the abdomen, pointing the way toward a new strategy for treating deadly abdominal aortic aneurysms.
MADISON — For the first time, researchers can get a high-resolution view of single blood stem cells thanks to a little help from microscopy and zebrafish.Researchers at the University of Wisconsin–Madison and the University of California San Diego have developed a method for scientists to track a single blood stem cell in a live organism and then describe the ultrastructure, or architecture, of that same cell using electron microscopy.
YourBio Health, Inc., developers of the world's first painless push-button blood collection device, was identified as a key contributor in the recent preprint published report in medRxiv.
Blood clots are thought to occur in as many as a third of patients hospitalized with COVID-19. In many cases these clots can be deadly, such as pulmonary embolisms—blood clots that travel to the lungs. In fact, in nearly one third of patients with COVID-19, these clots led to death.
Vitamin K is well-known for its blood clotting and bone building properties but today a new study published in Nature reports on a novel function for vitamin K.
Si no ha escuchado hablar sobre la enfermedad de las arterias periféricas, no es la única persona que no lo ha hecho. Aunque los médicos y las organizaciones de atención de la salud han concienciado mejor acerca de que la enfermedad cardíaca es la primera causa de muerte en todo el mundo,
Se você nunca ouviu falar da doença arterial periférica, você não está sozinho. Apesar de s médicos e as organizações de saúde já terem avançado na conscientização de que a doença cardíaca é a principal causa de morte em todo o mundo, a doença arterial periférica, mesmo sendo parte das doenças cardíacas, não é muito conhecida.
KSL Beutner Laboratories (Beutner), a global leader in immunologic testing for the diagnosis of bullous, vascular, connective tissue and inherited skin diseases, has launched a first-to-market indirect immunofluorescence (IIF) serum blood test in the U.S. that positively identifies laminin 332, an antigen associated with the chronic, debilitating autoimmune disease mucous membrane pemphigoid (MMP).
QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced today that its subsidiary, Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and services to hospitals, clinical laboratories and blood banks around the world, has earned the No. 1 ranking in the diagnostics industry for Overall Customer Satisfaction in the 2022 IMV ServiceTrak™ Awards for the fifth consecutive year. The ranking is based on interviews conducted with laboratory professionals, including Ortho's customers, from more than 1,200 clinical testing locations operating over 1,900 collective instruments. The prestigious annual IMV ServiceTrak™ Awards rankings affirm the continued power and impact of Ortho's innovative Ortho Care® Services and Informatics platform.
Women make up just 37.7% of all speakers at hematology and medical oncology board review lectures, according to a study published today in Blood Advances.
Clinical advances include treating hematologic cancers with effective targeted therapies, circulating tumor DNA as a biomarker for recurrence with colorectal liver metastases, and using magnetic resonance imaging (MRI) to guide surgical decisions for patients with lateral pelvic lymph node metastases in rectal cancer. Laboratory findings offer new understanding of the pancreatic cancer immune microenvironment, melanoma cell states, TP53 mutation status in acute myeloid leukemia (AML), and potential targets for metastatic prostate cancer and GNAS-mutant colorectal cancer.
DIFF-Line™ by CellaVision is a new, comprehensive solution for small labs. It consists of three instruments for smearing, staining, and analyzing peripheral blood smears: CellaVision® DC-1, RAL® SmearBox, and RAL® StainBox.
Neutrophils are a type of white blood cell that helps fight illness and disease by traveling to the body’s infected site to seek and destroy harmful pathogens.
Tesi Group will exhibit at the AACC Annual Scientific Meeting & Clinical Lab Expo alongside GPI USA, joined by Italian parent company Gpi Group, following up on an agreement recently signed by the two parties for the acquisition at the end of Q3 of 65% of the share capital of TESI by Gpi Group.
A pandemic-related shortage of a mundane item – tubes to collect blood samples from patients -- has caused headaches for health systems worldwide. But it may also have a silver lining: A lesson in how to reduce unneeded medical tests, whether or not there’s a shortage, according to a new study.
Researchers at Stanford University have developed “decoy receptor” molecules that inhibit the growth of both multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in mice. The molecules, described in a study to be published July 26 in the Journal of Experimental Medicine (JEM), were also found to be nontoxic in monkeys, suggesting they could be used to treat humans with either of these deadly diseases, which are two of the most common blood cancers around the world.
Rhinostics introduces another breakthrough in automated sample collection technologies with the launch of the patent-pending VERIstic™ Collection Device focused on small volume blood collection.
DiaSorin (FTSE MIB: DIA) announced today the FDA 510(k) clearance and the commercial launch in the US of the host-protein signature-based assay LIAISON® MeMed BV®
Patients are 20% less likely to die of sepsis because a new AI system developed at Johns Hopkins University catches symptoms hours earlier than traditional methods, an extensive hospital study demonstrates.
The system, created by a Johns Hopkins researcher whose young nephew died from sepsis, scours medical records and clinical notes to identify patients at risk of life-threatening complications. The work, which could significantly cut patient mortality from one of the top causes of hospital deaths worldwide, is published today in Nature Medicine and Nature Digital Medicine.
KT-8000 is equipped with auto-loader and sample mixer. This brand new fully automated hematology analyzer can free your hands and extend walk-away time. Smart counting mode can fit into more application scenarios than other hematology analyzers. Support both open vial/auto loading mode, and emergency sample first, and fit all the demands. Powerful data management unit has improved the work efficiency markedly.